Q32 Bio Inc.
QTTB
$1.74
$0.084.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.79M | -47.73M | -60.61M | -57.05M | -45.88M |
| Total Depreciation and Amortization | 483.00K | 487.00K | 491.00K | 492.00K | 495.00K |
| Total Amortization of Deferred Charges | 213.00K | 194.00K | 175.00K | 132.00K | 91.00K |
| Total Other Non-Cash Items | 4.74M | -11.03M | -10.78M | -5.27M | -7.46M |
| Change in Net Operating Assets | -11.29M | -9.64M | 3.73M | 30.12M | 32.02M |
| Cash from Operations | -65.65M | -67.72M | -67.00M | -31.58M | -20.73M |
| Capital Expenditure | -75.00K | -75.00K | -73.00K | -16.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.90M | 20.00M | 20.00M | 10.00M | 97.00K |
| Cash from Investing | 19.83M | 19.93M | 19.93M | 9.98M | 97.00K |
| Total Debt Issued | -53.16M | -46.16M | 7.00M | 12.50M | 12.50M |
| Total Debt Repaid | 2.81M | 2.81M | -5.90M | -11.10M | -5.20M |
| Issuance of Common Stock | 1.69M | 43.69M | 43.45M | 42.46M | 42.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 44.44M | 94.79M | 50.35M | 50.35M | 50.35M |
| Cash from Financing | -4.21M | 95.14M | 94.90M | 94.20M | 99.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.03M | 47.35M | 47.82M | 72.61M | 79.10M |